SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Amyris, Inc. – ‘10-Q’ for 3/31/21 – ‘EX-32.02’

On:  Friday, 5/7/21, at 5:19pm ET   ·   For:  3/31/21   ·   Accession #:  1365916-21-17   ·   File #:  1-34885

Previous ‘10-Q’:  ‘10-Q’ on 11/6/20 for 9/30/20   ·   Next:  ‘10-Q’ on 8/9/21 for 6/30/21   ·   Latest:  ‘10-Q’ on 5/10/23 for 3/31/23   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/07/21  Amyris, Inc.                      10-Q        3/31/21   96:10M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    998K 
 2: EX-4.02     Instrument Defining the Rights of Security Holders  HTML     51K 
 3: EX-4.03     Instrument Defining the Rights of Security Holders  HTML     39K 
 4: EX-5.01     Opinion of Counsel re: Legality                     HTML     36K 
 5: EX-10.01    Material Contract                                   HTML    168K 
 6: EX-10.02    Material Contract                                   HTML     35K 
 7: EX-31.01    Certification -- §302 - SOA'02                      HTML     31K 
 8: EX-31.02    Certification -- §302 - SOA'02                      HTML     31K 
 9: EX-32.01    Certification -- §906 - SOA'02                      HTML     29K 
10: EX-32.02    Certification -- §906 - SOA'02                      HTML     29K 
17: R1          Cover Page                                          HTML     82K 
18: R2          Condensed Consolidated Balance Sheets               HTML    155K 
19: R3          Condensed Consolidated Balance Sheets               HTML     54K 
                (Parentheticals)                                                 
20: R4          Condensed Consolidated Statements of Operations     HTML    125K 
21: R5          Condensed Consolidated Statements of Operations     HTML     33K 
                (Parentheticals)                                                 
22: R6          Condensed Consolidated Statements of Comprehensive  HTML     49K 
                Loss                                                             
23: R7          Condensed Consolidated Statements of Stockholders'  HTML    114K 
                Deficit and Mezzanine Equity                                     
24: R8          Condensed Consolidated Statements of Cash Flows     HTML    159K 
25: R9          Condensed Consolidated Statements of Stockholders'  HTML     30K 
                Deficit and Mezzanine Equity (Parentheticals)                    
26: R10         Basis of Presentation and Summary of Significant    HTML     41K 
                Accounting Policies                                              
27: R11         Balance Sheet Details                               HTML    115K 
28: R12         Fair Value Measurement                              HTML     78K 
29: R13         Debt                                                HTML    105K 
30: R14         Mezzanine Equity                                    HTML     30K 
31: R15         Stockholders' Deficit                               HTML     44K 
32: R16         Net Loss Per Share Attributable to Common           HTML     51K 
                Shareholders                                                     
33: R17         Commitments and Contingencies                       HTML     40K 
34: R18         Revenue Recognition and Contract Assets and         HTML    137K 
                Liabilities                                                      
35: R19         Related Party Transactions                          HTML     55K 
36: R20         Stock-based Compensation                            HTML     59K 
37: R21         Subsequent Events                                   HTML     34K 
38: R22         Basis of Presentation and Summary of Significant    HTML     43K 
                Accounting Policies (Policies)                                   
39: R23         Balance Sheet Details (Tables)                      HTML    129K 
40: R24         Fair Value Measurement (Tables)                     HTML     73K 
41: R25         Debt (Tables)                                       HTML    101K 
42: R26         Stockholders' Deficit (Tables)                      HTML     42K 
43: R27         Loss Per Share (Tables)                             HTML     52K 
44: R28         Revenue Recognition and Contract Assets and         HTML    127K 
                Liabilities (Tables)                                             
45: R29         Related Party Transactions (Tables)                 HTML     53K 
46: R30         Stock-based Compensation (Tables)                   HTML     62K 
47: R31         Basis of Presentation and Summary of Significant    HTML     31K 
                Accounting Policies - Narrative (Details)                        
48: R32         Balance Sheet Details - Allowance for Doubtful      HTML     34K 
                Accounts (Details)                                               
49: R33         Balance Sheet Details - Inventories (Details)       HTML     36K 
50: R34         Balance Sheet Details - Deferred Cost of Products   HTML     32K 
                Sold - Related Party (Details)                                   
51: R35         Balance Sheet Details - Additional Information      HTML     53K 
                (Details)                                                        
52: R36         Balance Sheet Details - Prepaid Expenses and Other  HTML     38K 
                Current Assets (Details)                                         
53: R37         Balance Sheet Details - Property, Plant and         HTML     46K 
                Equipment (Details)                                              
54: R38         Balance Sheet Details - Depreciation and            HTML     30K 
                Amortization (Details)                                           
55: R39         Balance Sheet Details - Right-of-use Assets and     HTML     36K 
                Related Lease Liabilities (Details)                              
56: R40         Balance Sheet Details - Maturities of Financing     HTML     89K 
                and Operating Leases (Details)                                   
57: R41         Balance Sheet Details - Other Assets (Details)      HTML     36K 
58: R42         Balance Sheet Details - Accrued and Other Current   HTML     48K 
                Liabilities (Details)                                            
59: R43         Balance Sheet Details - Other Noncurrent            HTML     41K 
                Liabilities (Details)                                            
60: R44         Fair Value Measurement - Fair Value, Assets, and    HTML     57K 
                Liabilities Measured on Recurring Basis (Details)                
61: R45         Fair Value Measurement - Fair Value of Debt -       HTML     62K 
                Foris Convertible Note (LSA Amendment) (Details)                 
62: R46         Fair Value Measurement - Fair Value of Debt -       HTML     54K 
                Senior Convertible Notes (Details)                               
63: R47         Fair Value Measurement - Fair Value, Liabilities    HTML     39K 
                Measured on Recurring Basis, Unobservable Input                  
                Reconciliation (Details)                                         
64: R48         Fair Value Measurement - Reconciliation for         HTML     38K 
                Compound Embedded Derivative Liability (Details)                 
65: R49         Fair Value Measurement - Freestanding Derivative    HTML     40K 
                Instruments (Details)                                            
66: R50         Fair Value Measurement - Market-based Assumption    HTML     50K 
                and Estimates for Compound Embedded Derivative                   
                Liabilities Valuation (Details)                                  
67: R51         Fair Value Measurement - Financial Assets and       HTML     31K 
                Liabilities (Details)                                            
68: R52         Debt - Debt Components (Details)                    HTML     82K 
69: R53         Debt - Future Minimum Payments (Details)            HTML     68K 
70: R54         Debt - Senior Convertible Notes (Details)           HTML     42K 
71: R55         Debt - Schottfield Debt (Details)                   HTML     38K 
72: R56         Debt - DSM Amendments and Repayment (Details)       HTML     59K 
73: R57         Mezzanine Equity (Details Textual)                  HTML     33K 
74: R58         Stockholders' Deficit - Warrant Activity (Details)  HTML     70K 
75: R59         Net Loss Per Share Attributable to Common           HTML     63K 
                Shareholders - Calculation of Basic and Diluted                  
                Net Loss Per Share of Common Stock (Details)                     
76: R60         Net Loss Per Share Attributable to Common           HTML     43K 
                Shareholders - Antidilutive Securities Excluded                  
                From Computation of Earnings Per Share (Details)                 
77: R61         Commitments and Contingencies - Guarantor           HTML     35K 
                Arrangements (Details)                                           
78: R62         Revenue Recognition and Contract Assets and         HTML     80K 
                Liabilities - Disaggregation of Revenue (Details)                
79: R63         Revenue Recognition and Contract Assets and         HTML     76K 
                Liabilities - Revenue in Connection With                         
                Significant Revenue Agreement (Details)                          
80: R64         Revenue Recognition and Contract Assets and         HTML     42K 
                Liabilities - Contract Balances (Details)                        
81: R65         Revenue Recognition and Contract Assets and         HTML     44K 
                Liabilities - Remaining Performance Obligations                  
                (Details)                                                        
82: R66         Revenue Recognition and Contract Assets and         HTML     51K 
                Liabilities - DSM License Agreement and Contract                 
                Asset (Details)                                                  
83: R67         Revenue Recognition and Contract Assets and         HTML     40K 
                Liabilities - DSM Performance Agreement (Details)                
84: R68         Revenue Recognition and Contract Assets and         HTML     39K 
                Liabilities - DSM Ingredients Collaboration                      
                (Details)                                                        
85: R69         Revenue Recognition and Contract Assets and         HTML     48K 
                Liabilities - Yifan Agreement (Details)                          
86: R70         Related Party Transactions - Related Party Debt     HTML     53K 
                (Details)                                                        
87: R71         Related Party Transactions - Related Party          HTML     39K 
                Accounts Receivable (Details)                                    
88: R72         Stock-based Compensation - Share-based              HTML     78K 
                Compensation, Stock Options and Stock Appreciation               
                Rights Award Activity (Details)                                  
89: R73         Stock-based Compensation - Temporal Display of      HTML     64K 
                Share-based Compensation, Restricted Stock and                   
                Restricted Stock Units Activity (Details)                        
90: R74         Stock-based Compensation - Employee Service         HTML     37K 
                Share-based Compensation, Allocation of Recognized               
                Period Costs (Details)                                           
91: R75         Stock-based Compensation - Additional Information   HTML     45K 
                (Details)                                                        
92: R76         Subsequent Events - Primary and Secondary Offering  HTML     51K 
                (Details)                                                        
94: XML         IDEA XML File -- Filing Summary                      XML    170K 
16: XML         XBRL Instance -- amrs-20210331_htm                   XML   2.64M 
93: EXCEL       IDEA Workbook of Financial Reports                  XLSX    113K 
12: EX-101.CAL  XBRL Calculations -- amrs-20210331_cal               XML    336K 
13: EX-101.DEF  XBRL Definitions -- amrs-20210331_def                XML    889K 
14: EX-101.LAB  XBRL Labels -- amrs-20210331_lab                     XML   2.08M 
15: EX-101.PRE  XBRL Presentations -- amrs-20210331_pre              XML   1.31M 
11: EX-101.SCH  XBRL Schema -- amrs-20210331                         XSD    260K 
95: JSON        XBRL Instance as JSON Data -- MetaLinks              439±   665K 
96: ZIP         XBRL Zipped Folder -- 0001365916-21-000017-xbrl      Zip    400K 


‘EX-32.02’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

Exhibit 32.02

Certification of CFO Furnished Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant To
Section 906 of The Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Amyris, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof, I, Han Kieftenbeld, Chief Financial Officer of the Company, certify for the purposes of section 1350 of chapter 63 of title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge,

(i) the Quarterly Report of the Company on Form 10-Q for the quarterly period ended March 31, 2021 (the “Report”), fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 7, 2021
Han Kieftenbeld
Chief Financial Officer
(Principal Financial Officer)



1


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:5/7/21424B7
For Period end:3/31/218-K
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/16/23  Amyris, Inc.                      10-K       12/31/22  150:18M
 3/09/22  Amyris, Inc.                      10-K       12/31/21  165:21M


1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/07/21  Amyris, Inc.                      S-3ASR      4/07/21    6:871K                                   Donnelley … Solutions/FA
Top
Filing Submission 0001365916-21-000017   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 2, 7:03:47.1pm ET